{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:12:41Z","timestamp":1757628761015,"version":"3.44.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,10]]},"DOI":"10.7759\/cureus.91962","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:18:50Z","timestamp":1757499530000},"source":"Crossref","is-referenced-by-count":0,"title":["Remimazolam as a Novel Option for Procedural Sedation: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Hubert","family":"Ziembicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Skrzypska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Wr\u00f3blewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kacper","family":"Zagaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Wasilewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Wojtczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15213","article-title":"Procedural sedation: providing the missing definition","volume":"76","author":"Green SM","year":"2021","unstructured":"Green SM, Irwin MG, Mason KP. Procedural sedation: providing the missing definition. Anaesthesia. 2021, 76:598-601. 10.1111\/anae.15213","journal-title":"Anaesthesia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.11.050","article-title":"Pharmacological agents for procedural sedation and analgesia in the emergency department and intensive care unit: a systematic review and network meta-analysis of randomised trials","volume":"132","author":"Sharif S","year":"2024","unstructured":"Sharif S, Kang J, Sadeghirad B, et al.. Pharmacological agents for procedural sedation and analgesia in the emergency department and intensive care unit: a systematic review and network meta-analysis of randomised trials. Br J Anaesth. 2024, 132:491-506. 10.1016\/j.bja.2023.11.050","journal-title":"Br J Anaesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/bjaceaccp\/mks016","article-title":"Procedural sedation for adult patients: an overview","volume":"12","author":"Blayney MR","year":"2012","unstructured":"Blayney MR. Procedural sedation for adult patients: an overview. Contin Educ Anaesth Crit Care Pain. 2012, 12:176-80. 10.1093\/bjaceaccp\/mks016","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"ref4","article-title":"Procedural Sedation","author":"Benzoni T","year":"2025","unstructured":"Benzoni T, Cascella M. Procedural Sedation. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000000683","article-title":"European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults","volume":"35","author":"Hinkelbein J","year":"2018","unstructured":"Hinkelbein J, Lamperti M, Akeson J, et al.. European Society of Anaesthesiology and European Board of Anaesthesiology guidelines for procedural sedation and analgesia in adults. Eur J Anaesthesiol. 2018, 35:6-24. 10.1097\/EJA.0000000000000683","journal-title":"Eur J Anaesthesiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2013.10.015","article-title":"Clinical policy: procedural sedation and analgesia in the emergency department","volume":"63","author":"Godwin SA","year":"2014","unstructured":"Godwin SA, Burton JH, Gerardo CJ, Hatten BW, Mace SE, Silvers SM, Fesmire FM. Clinical policy: procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2014, 63:247-58. 10.1016\/j.annemergmed.2013.10.015","journal-title":"Ann Emerg Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645090-00001","article-title":"Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation","volume":"45","author":"Gan TJ","year":"2006","unstructured":"Gan TJ. Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation. Clin Pharmacokinet. 2006, 45:855-69. 10.2165\/00003088-200645090-00001","journal-title":"Clin Pharmacokinet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.690875","article-title":"Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent","volume":"12","author":"Kilpatrick GJ","year":"2021","unstructured":"Kilpatrick GJ. Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent. Front Pharmacol. 2021, 12:690875. 10.3389\/fphar.2021.690875","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.84","article-title":"Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers","volume":"51","author":"Mandema JW","year":"1992","unstructured":"Mandema JW, Tuk B, van Steveninck AL, Breimer DD, Cohen AF, Danhof M. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther. 1992, 51:715-28. 10.1038\/clpt.1992.84","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff AN","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J, et al.. Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int. 2021, 13:594-607. 10.3390\/neurolint13040059","journal-title":"Neurol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(97)01118-8","article-title":"The benzodiazepine binding site of GABAA receptors","volume":"18","author":"Sigel E","year":"1997","unstructured":"Sigel E, Buhr A. The benzodiazepine binding site of GABAA receptors. Trends Pharmacol Sci. 1997, 18:425-9. 10.1016\/S0165-6147(97)01118-8","journal-title":"Trends Pharmacol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14270","article-title":"Potential strategy for assessing QT\/QTc interval for drugs that produce rapid changes in heart rate: electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization","volume":"86","author":"Kleiman RB","year":"2020","unstructured":"Kleiman RB, Darpo B, Thorn M, Stoehr T, Schippers F. Potential strategy for assessing QT\/QTc interval for drugs that produce rapid changes in heart rate: electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization. Br J Clin Pharmacol. 2020, 86:1600-9. 10.1111\/bcp.14270","journal-title":"Br J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000267503.85085.c0","article-title":"CNS 7056: a novel ultra-short-acting benzodiazepine","volume":"107","author":"Kilpatrick GJ","year":"2007","unstructured":"Kilpatrick GJ, McIntyre MS, Cox RF, et al.. CNS 7056: a novel ultra-short-acting benzodiazepine. Anesthesiology. 2007, 107:60-6. 10.1097\/01.anes.0000267503.85085.c0","journal-title":"Anesthesiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181ae8460","article-title":"Is anesthesiology going soft?: Trends in fragile pharmacology","volume":"111","author":"Egan TD","year":"2009","unstructured":"Egan TD. Is anesthesiology going soft?: Trends in fragile pharmacology. Anesthesiology. 2009, 111:229-30. 10.1097\/ALN.0b013e3181ae8460","journal-title":"Anesthesiology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S186759","article-title":"Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system","volume":"13","author":"Freyer N","year":"2019","unstructured":"Freyer N, Kn\u00f6spel F, Damm G, et al.. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug Des Devel Ther. 2019, 13:1033-47. 10.2147\/DDDT.S186759","journal-title":"Drug Des Devel Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4097\/kja.22297","article-title":"Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent","volume":"75","author":"Kim SH","year":"2022","unstructured":"Kim SH, Fechner J. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent. Korean J Anesthesiol. 2022, 75:307-15. 10.4097\/kja.22297","journal-title":"Korean J Anesthesiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003103","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics","volume":"132","author":"Sch\u00fcttler J","year":"2020","unstructured":"Sch\u00fcttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020, 132:636-51. 10.1097\/ALN.0000000000003103","journal-title":"Anesthesiology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173886","article-title":"A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam","volume":"896","author":"Io T","year":"2021","unstructured":"Io T, Saunders R, Pesic M, Petersen KU, Stoehr T. A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam. Eur J Pharmacol. 2021, 896:173886. 10.1016\/j.ejphar.2021.173886","journal-title":"Eur J Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/290514a0","article-title":"Selective antagonists of benzodiazepines","volume":"290","author":"Hunkeler W","year":"1981","unstructured":"Hunkeler W, M\u00f6hler H, Pieri L, et al.. Selective antagonists of benzodiazepines. Nature. 1981, 290:514-6. 10.1038\/290514a0","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.02.006","article-title":"Psychomotor recovery following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote","volume":"42","author":"Chen X","year":"2020","unstructured":"Chen X, Sang N, Song K, et al.. Psychomotor recovery following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote. Clin Ther. 2020, 42:614-24. 10.1016\/j.clinthera.2020.02.006","journal-title":"Clin Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1990.tb03161.x","article-title":"Recovery from total intravenous anaesthesia. Propofol versus midazolam-flumazenil","volume":"34","author":"Steib A","year":"1990","unstructured":"Steib A, Freys G, Jochum D, Ravanello J, Schaal JC, Otteni JC. Recovery from total intravenous anaesthesia. Propofol versus midazolam-flumazenil. Acta Anaesthesiol Scand. 1990, 34:632-5. 10.1111\/j.1399-6576.1990.tb03161.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000877","article-title":"Remimazolam for anaesthesia or sedation","volume":"33","author":"Sneyd JR","year":"2020","unstructured":"Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020, 33:506-11. 10.1097\/ACO.0000000000000877","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S384155","article-title":"Remimazolam: an updated review of a new sedative and anaesthetic","volume":"16","author":"Hu Q","year":"2022","unstructured":"Hu Q, Liu X, Wen C, Li D, Lei X. Remimazolam: an updated review of a new sedative and anaesthetic. Drug Des Devel Ther. 2022, 16:3957-74. 10.2147\/DDDT.S384155","journal-title":"Drug Des Devel Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-021-02915-x","article-title":"Re-sleeping after reversal of remimazolam by flumazenil","volume":"35","author":"Yamamoto T","year":"2021","unstructured":"Yamamoto T, Kurabe M, Kamiya Y. Re-sleeping after reversal of remimazolam by flumazenil. J Anesth. 2021, 35:322. 10.1007\/s00540-021-02915-x","journal-title":"J Anesth"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01544-8","article-title":"Remimazolam: a review in procedural sedation","volume":"81","author":"Lee A","year":"2021","unstructured":"Lee A, Shirley M. Remimazolam: a review in procedural sedation. Drugs. 2021, 81:1193-201. 10.1007\/s40265-021-01544-8","journal-title":"Drugs"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik LJ","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012, 115:274-83. 10.1213\/ANE.0b013e31823f0c28","journal-title":"Anesth Analg"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ph17040473","article-title":"Pharmacokinetics, pharmacodynamics, and side effects of midazolam: a review and case example","volume":"17","author":"Peter JU","year":"2024","unstructured":"Peter JU, Dieudonn\u00e9 P, Zolk O. Pharmacokinetics, pharmacodynamics, and side effects of midazolam: a review and case example. Pharmaceuticals (Basel). 2024, 17:4-6. 10.3390\/ph17040473","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.002","article-title":"AGA Institute review of endoscopic sedation","volume":"133","author":"Cohen LB","year":"2007","unstructured":"Cohen LB, Delegge MH, Aisenberg J, Brill JV, Inadomi JM, Kochman ML, Piorkowski JD Jr. AGA Institute review of endoscopic sedation. Gastroenterology. 2007, 133:675-701. 10.1053\/j.gastro.2007.06.002","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjae.2022.02.006","article-title":"Developments in procedural sedation for adults","volume":"22","author":"Sneyd JR","year":"2022","unstructured":"Sneyd JR. Developments in procedural sedation for adults. BJA Educ. 2022, 22:258-64. 10.1016\/j.bjae.2022.02.006","journal-title":"BJA Educ"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol","volume":"57","author":"Sahinovic MM","year":"2018","unstructured":"Sahinovic MM, Struys MM, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018, 57:1539-58. 10.1007\/s40262-018-0672-3","journal-title":"Clin Pharmacokinet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317040-00003","article-title":"Propofol: a review of its use in intensive care sedation of adults","volume":"17","author":"McKeage K","year":"2003","unstructured":"McKeage K, Perry CM. Propofol: a review of its use in intensive care sedation of adults. CNS Drugs. 2003, 17:235-72. 10.2165\/00023210-200317040-00003","journal-title":"CNS Drugs"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2024.11.018","article-title":"The diverse effects of ketamine, jack-of-all-trades: a narrative review","volume":"134","author":"Richards ND","year":"2025","unstructured":"Richards ND, Howell SJ, Bellamy MC, Beck J. The diverse effects of ketamine, jack-of-all-trades: a narrative review. Br J Anaesth. 2025, 134:649-61. 10.1016\/j.bja.2024.11.018","journal-title":"Br J Anaesth"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043382846","article-title":"Propofol: therapeutic indications and side-effects","volume":"10","author":"Marik PE","year":"2004","unstructured":"Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des. 2004, 10:3639-49. 10.2174\/1381612043382846","journal-title":"Curr Pharm Des"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew126","article-title":"The effect of propofol on haemodynamics: cardiac output, venous return, mean systemic filling pressure, and vascular resistances","volume":"116","author":"de Wit F","year":"2016","unstructured":"de Wit F, van Vliet AL, de Wilde RB, et al.. The effect of propofol on haemodynamics: cardiac output, venous return, mean systemic filling pressure, and vascular resistances. Br J Anaesth. 2016, 116:784-9. 10.1093\/bja\/aew126","journal-title":"Br J Anaesth"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010373098","article-title":"The intravenous anesthetic propofol inhibits human L-type calcium channels by enhancing voltage-dependent inactivation","volume":"51","author":"Fassl J","year":"2011","unstructured":"Fassl J, High KM, Stephenson ER, Yarotskyy V, Elmslie KS. The intravenous anesthetic propofol inhibits human L-type calcium channels by enhancing voltage-dependent inactivation. J Clin Pharmacol. 2011, 51:719-30. 10.1177\/0091270010373098","journal-title":"J Clin Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12936","article-title":"Ionic mechanisms underlying the negative chronotropic action of propofol on sinoatrial node automaticity in guinea pig heart","volume":"172","author":"Kojima A","year":"2015","unstructured":"Kojima A, Ito Y, Kitagawa H, Matsuura H. Ionic mechanisms underlying the negative chronotropic action of propofol on sinoatrial node automaticity in guinea pig heart. Br J Pharmacol. 2015, 172:799-814. 10.1111\/bph.12936","journal-title":"Br J Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173303","article-title":"Propofol induces the elevation of intracellular calcium via morphological changes in intracellular organelles, including the endoplasmic reticulum and mitochondria","volume":"884","author":"Urabe T","year":"2020","unstructured":"Urabe T, Yanase Y, Motoike S, et al.. Propofol induces the elevation of intracellular calcium via morphological changes in intracellular organelles, including the endoplasmic reticulum and mitochondria. Eur J Pharmacol. 2020, 884:173303. 10.1016\/j.ejphar.2020.173303","journal-title":"Eur J Pharmacol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263395","article-title":"Characterization of intracellular calcium mobilization induced by remimazolam, a newly approved intravenous anesthetic","volume":"17","author":"Urabe T","year":"2022","unstructured":"Urabe T, Miyoshi H, Narasaki S, et al.. Characterization of intracellular calcium mobilization induced by remimazolam, a newly approved intravenous anesthetic. PLoS One. 2022, 17:e0263395. 10.1371\/journal.pone.0263395","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15495","article-title":"Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials","volume":"11","author":"Chang Y","year":"2023","unstructured":"Chang Y, Huang YT, Chi KY, Huang YT. Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials. PeerJ. 2023, 11:e15495. 10.7717\/peerj.15495","journal-title":"PeerJ"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.22.16631-9","article-title":"Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes","volume":"88","author":"Tang Y","year":"2022","unstructured":"Tang Y, Yang X, Yu Y, et al.. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes. Minerva Anestesiol. 2022, 88:939-49. 10.23736\/S0375-9393.22.16631-9","journal-title":"Minerva Anestesiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2007.12.005","article-title":"Adverse events associated with ketamine for procedural sedation in adults","volume":"26","author":"Strayer RJ","year":"2008","unstructured":"Strayer RJ, Nelson LS. Adverse events associated with ketamine for procedural sedation in adults. Am J Emerg Med. 2008, 26:985-1028. 10.1016\/j.ajem.2007.12.005","journal-title":"Am J Emerg Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2010.02283.x","article-title":"Ketamine reduce left ventricular systolic and diastolic function in patients with ischaemic heart disease","volume":"54","author":"Jakobsen CJ","year":"2010","unstructured":"Jakobsen CJ, Torp P, Vester AE, Folkersen L, Thougaard A, Sloth E. Ketamine reduce left ventricular systolic and diastolic function in patients with ischaemic heart disease. Acta Anaesthesiol Scand. 2010, 54:1137-44. 10.1111\/j.1399-6576.2010.02283.x","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000002126","article-title":"Remimazolam for procedural sedation: a systematic review with meta-analyses and trial sequential analyses","volume":"42","author":"Pingel L","year":"2025","unstructured":"Pingel L, Maagaard M, Tvarn\u00f8 CD, et al.. Remimazolam for procedural sedation: a systematic review with meta-analyses and trial sequential analyses. Eur J Anaesthesiol. 2025, 42:298-312. 10.1097\/EJA.0000000000002126","journal-title":"Eur J Anaesthesiol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2016.11.004","article-title":"Increase in the systemic exposure of primary metabolites of Midazolam in rat arising from CYP inhibition or hepatic dysfunction","volume":"32","author":"Hasegawa T","year":"2017","unstructured":"Hasegawa T, Nakanishi S, Minami K, Higashino H, Kataoka M, Shitara Y, Yamashita S. Increase in the systemic exposure of primary metabolites of Midazolam in rat arising from CYP inhibition or hepatic dysfunction. Drug Metab Pharmacokinet. 2017, 32:69-76. 10.1016\/j.dmpk.2016.11.004","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1581280","article-title":"The comparison of remimazolam and midazolam in bronchoscopic sedation: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"AbuJwaid YK","year":"2025","unstructured":"AbuJwaid YK, Deeb S, Amro AM, Asbeh YA. The comparison of remimazolam and midazolam in bronchoscopic sedation: a systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2025, 12:1581280. 10.3389\/fmed.2025.1581280","journal-title":"Front Med (Lausanne)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2015.08.062","article-title":"A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy","volume":"83","author":"Pambianco DJ","year":"2016","unstructured":"Pambianco DJ, Borkett KM, Riff DS, Winkle PJ, Schwartz HI, Melson TI, Wilhelm-Ogunbiyi K. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016, 83:984-92. 10.1016\/j.gie.2015.08.062","journal-title":"Gastrointest Endosc"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.655042","article-title":"Efficacy and safety of remimazolam in endoscopic sedation-a systematic review and meta-analysis","volume":"8","author":"Zhu X","year":"2021","unstructured":"Zhu X, Wang H, Yuan S, et al.. Efficacy and safety of remimazolam in endoscopic sedation-a systematic review and meta-analysis. Front Med (Lausanne). 2021, 8:655042. 10.3389\/fmed.2021.655042","journal-title":"Front Med (Lausanne)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.09.015","article-title":"Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy","volume":"155","author":"Pastis NJ","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, et al.. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019, 155:137-46. 10.1016\/j.chest.2018.09.015","journal-title":"Chest"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2024.04.006","article-title":"Efficacy and cost analysis of intravenous conscious sedation for long oral surgery procedures","volume":"62","author":"Hassan H","year":"2024","unstructured":"Hassan H, Shado R, Novo Pereira I, Mistry M, Craig D. Efficacy and cost analysis of intravenous conscious sedation for long oral surgery procedures. Br J Oral Maxillofac Surg. 2024, 62:523-38. 10.1016\/j.bjoms.2024.04.006","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01299-8","article-title":"Remimazolam: first approval","volume":"80","author":"Keam SJ","year":"2020","unstructured":"Keam SJ. Remimazolam: first approval. Drugs. 2020, 80:625-33. 10.1007\/s40265-020-01299-8","journal-title":"Drugs"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2022.02.040","article-title":"Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study","volume":"129","author":"Chae D","year":"2022","unstructured":"Chae D, Kim HC, Song Y, Choi YS, Han DW. Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study. Br J Anaesth. 2022, 129:49-57. 10.1016\/j.bja.2022.02.040","journal-title":"Br J Anaesth"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2025.02.038","article-title":"Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation","volume":"135","author":"Eleveld DJ","year":"2025","unstructured":"Eleveld DJ, Colin PJ, Van den Berg JP, Koomen JV, Stoehr T, Struys MM. Development and analysis of a remimazolam pharmacokinetics and pharmacodynamics model with proposed dosing and concentrations for anaesthesia and sedation. Br J Anaesth. 2025, 135:206-17. 10.1016\/j.bja.2025.02.038","journal-title":"Br J Anaesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/413802-remimazolam-as-a-novel-option-for-procedural-sedation-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:18:51Z","timestamp":1757499531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/413802-remimazolam-as-a-novel-option-for-procedural-sedation-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":52,"URL":"https:\/\/doi.org\/10.7759\/cureus.91962","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}